loadpatents
name:-0.0083489418029785
name:-0.007188081741333
name:-0.0010318756103516
PRIETO VALTUENA; Jes s Patent Filings

PRIETO VALTUENA; Jes s

Patent Applications and Registrations

Patent applications and USPTO patent grants for PRIETO VALTUENA; Jes s.The latest application filed is for "use of metalloprotease inhibitors in the treatment of polycystic liver diseases".

Company Profile
0.5.8
  • PRIETO VALTUENA; Jes s - Pamplona Gipuzkoa
  • PRIETO VALTUENA; Jes s - Pamplona - Navarra ES
  • Prieto Valtuena; Jes s - Navarra ES
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use Of Metalloprotease Inhibitors In The Treatment Of Polycystic Liver Diseases
App 20160045463 - BANALES ASURMENDI; Jes s Maria ;   et al.
2016-02-18
Peptides With The Capacity To Bind To Interleukin-10 (il-10)
App 20130064790 - MANTEROLA CAREAGA; Lorea ;   et al.
2013-03-14
Use Of A Cytokine From The Interleukin-6 Family In The Preparation Of A Composition For Combined Administration With Interferon-alpha
App 20110027224 - Aldabe Arregui; Rafael ;   et al.
2011-02-03
Treatment of hepatitis C with compositions comprising oncostatin M and interferon alpha
Grant 7,829,077 - Aldabe Arregui , et al. November 9, 2
2010-11-09
Peptides With Capacity To Bind To Scurfin And Applications
App 20100267623 - Casares Lagar; Ines Noelia ;   et al.
2010-10-21
PEPTIDES WITH THE CAPACITY TO BIND TO TRANSFORMING GROWTH FACTOR beta 1 (TGF-beta 1)
App 20100222280 - DOTOR HERRER AS; JAVIER ;   et al.
2010-09-02
Peptides With Capacity For Binding With Interleukine 10 (il-10)
App 20100168015 - Manterola Careaga; Lorea ;   et al.
2010-07-01
Use of cardiotrophin in liver diseases
Grant 7,732,397 - Bustos De Abajo , et al. June 8, 2
2010-06-08
TGF.beta.1-inhibitor peptides
Grant 7,528,226 - Ezquerro Saenz , et al. May 5, 2
2009-05-05
Method of treatment of viral hepatitis C with interferon alpha 5
Grant 7,501,392 - Prieto Valtuena , et al. March 10, 2
2009-03-10
Utilization of interferon alpha 5 in the treatment of viral hepatopathies
Grant 6,995,133 - Prieto Valtuena , et al. February 7, 2
2006-02-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed